This Medical News article describes how ultrapotent antibodies discovered in patients who recovered from COVID-19 could be key players in new treatments and vaccines.
This Viewpoint describes how the updated functionality of PubMed could be useful to clinicians searching for answers to important clinical questions in real time.
This study examines the antibody responses to a third dose (100 μg) of the mRNA-1273 SARS-CoV-2 vaccine among kidney transplant recipients in France who had not responded to 2 doses of the vaccine.
This Viewpoint discusses the Comprehensive Care for Joint Replacement model created by the Centers for Medicare & Medicaid Services and how it and other payment reforms can help reduce disparities in joint replacements and other high-priority conditions nationally.
This Viewpoint highlights why complementary approaches, which often have received less attention, are necessary to enhance the evidence needed to inform care for older adults.
This study examines the relationship between age and neutralizing antibody titers against the SARS-CoV-2 USA-WA1/2020 strain and the P.1 variant after 2 doses of the BNT162b2 vaccine.
This Medical News feature examines the debate over which patients with Alzheimer disease, if any, might benefit from the newly approved drug aducanumab.
This study compares age-adjusted mortality rates before and during the COVID-19 pandemic among Latino and White individuals living in Los Angeles County.
This Viewpoint discusses the recently approved drug aducanumab as a treatment for Alzheimer disease and whether it might be covered under Medicare, a decision made by CMS administrators.
This randomized trial assesses the effect of a single dose of azithromycin vs placebo on absence of COVID-19 symptoms at posttreatment day 14 among outpatients with SARS-CoV-2 infection.
This cohort study reports the prevalence of long-term symptoms in children and adolescents who had recovered from acute SARS-CoV-2 infection.
This Viewpoint proposes several important areas of surveillance expansion by US public health agencies and other institutions for COVID-19 testing, vaccination, infection, and mortality rates.
This Medical News article discusses the duration of immunity after SARS-CoV-2 infection.
This cohort study explores the risk of SARS-CoV-2 infection in pregnant women vaccinated with BNT162b2 vaccine (Pfizer-BioNTech) vs those unvaccinated.
This prospective meta-analysis estimates the association between administration of IL-6 antagonists compared with usual care or placebo and 28-day all-cause mortality and other outcomes.
This study assesses changes in COVID-19 vaccination rates before and after the Ohio vaccine lottery announcement compared with national rates to control for the expansion of vaccine indications to adolescents.
Create a personal account or sign in to: